| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
4e-05 |
| mRNA |
AZD7762 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
5e-05 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0001 |
| mRNA |
TG-100-115 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0003 |
| mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0004 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0004 |
| mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0004 |
| mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0004 |
| mRNA |
CCT036477 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.0006 |
| mRNA |
ML320 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0007 |